Real-Time Oncology Review Quickly Grows Popular; Venclexta Is Latest To Join Pilot

 
• By Bridget Silverman

Genentech/AbbVie drug becomes the seventh product known to be pilot-testing US FDA's new pathway; our infographic details the program's goals and how it has been used so far for more efficient reviews of supplemental oncology indications.

The hands of the captain and a steering wheel boat port services

More from Product Reviews

More from Pink Sheet